COMPARE · Data as of August 21, 2026
PRVA vs VEEV
Verdict: Side-by-side breakdown using the Bull Rankings model. PRVA scored 56.3, VEEV scored 77.8 — VEEV leads.
Compare another set
PRVA
Privia Health Group, Inc.
56.3
$21.12 · $2.7B
fundamentals as of
Score gap
21.5
VEEV leads
VEEV
Veeva Systems Inc.
77.8
$247.90 · $40.3B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestVEEV43.9x
- Fastest growthPRVA+24.1%
- Strongest balance sheetPRVA0.01
- Highest qualityVEEV77 / 100
- Largest discount to fair valuePRVA-14%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
PRVA
stronger →← stronger
VEEV
45
Qualityreturns · margins · balance sheet
77
91
Growthrevenue & earnings expansion
91
44
Valuevaluation vs sector peers
67
VEEV is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
PRVA
VEEV
$131mC
FCF
$1.7bC+
+24.1%A-
Rev
+16.2%B+
0.01A
D/E
0.01A-
96.0xD
P/E
43.9xC
4.50D
PEG
1.13B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
PRVA
VEEV
14% below
Price vs fair valuelower is cheaper
30% above
~9%/yr
Growth the price implies10-yr FCF · lower = less priced in
~14%/yr
-8%
1-yr DCF upside
-30%
+16%
5-yr DCF upside
-23%
+63%
10-yr DCF upside
-11%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
PRVA
Why this score
- Diluting shareholders
VEEV
No notable signals flagged.
The companies
PRVAPrivia Health Group, Inc.
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +50% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 96.0x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
VEEVVeeva Systems Inc.
Why now
Health Information Services · market cap $40.3b. Down 20% from 52-week high of $310.50 — deep drawdown territory. Revenue growing +16%, comfortably above the S&P median. 28 sell-side analysts rate this a Buy with a mean 1-yr target of $251.43 (implying +1% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 177% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 44x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 12.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where PRVA and VEEV diverge
On the headline score the gap is 21.5 points in favor of VEEV. The widest single difference is Quality, where VEEV leads by 32.7 points.
- QualityPRVA 44.6 · VEEV 77.3VEEV +32.7
- ValuePRVA 44.0 · VEEV 67.4VEEV +23.4
- GrowthPRVA 91.1 · VEEV 90.6level
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.